Key result
Cangrelor achieves complete thrombus disaggregation and vessel recanalization in a murine thrombosis model.
Why the study?
Existing arterial thrombosis models are limited by biphasic thrombus dynamics, which prevents assessing thrombus destabilization, disaggregation, or thrombolysis after pharmacological treatment.
Does post-onset administration of antithrombotic agents disaggregate or destabilize a pre-formed stable thrombus in a murine FeCl3-induced carotid artery thrombosis model?
Does post-onset administration of antithrombotic agents disaggregate or destabilize a pre-formed stable thrombus in a murine FeCl3-induced carotid artery thrombosis model?
A novel 2-spot FeCl3-induced murine stable thrombosis model successfully allows for the evaluation of the curative effects of antithrombotic and thrombolytic agents on preformed arterial thrombi.
Answers are grounded in this paper and cite their sources.
Extends antithrombotic testing to preformed stable thrombi in mice; leaves open translation to human arterial thrombosis.
Over recent decades, numerous experimental models have been developed to investigate arterial thrombosis and evaluate the efficacy of anti-thrombotic treatment. A major limitation of these models lies in the biphasic dynamics of a thrombus, which prevents assessment of its destabilization/disaggregation/thrombolysis after pharmacological treatment. In this study, we developed a stable thrombosis model based on the external application of two 7.5% FeCl 3 -saturated Whatman papers to the carotid artery. Histological analysis and TEM revealed no exposure of the subendothelial matrix. Intravital microscopy identified platelets as the major cell type adhering to the injured vessel walls with plateau-type kinetics of thrombus formation during the experiment. Doppler probe measurements detected the arrest of blood flow at 14±3 min when the thrombus reached its maximum area. Intravital and histological studies showed that the thrombus composition changed with the time after injury. At 45 min, the thrombi were enriched in RBCs with a shift in the platelet-fibrin composition towards fibrin predominance as compared to thrombi at 15 min. To evaluate the efficacy of known antithrombotic agents in this model, inhibitors were injected 15 min after initiation of thrombosis. Video-microscopy revealed that 0.4 mg/mL Cangrelor (P2Y 12 inhibitor) or 4 mg/mL GR 144053 trihydrochloride (αIIbβ3 blocker) induced complete disaggregation, and 50 IU/mL heparin or 4 mg/mL rtPA destabilization of the thrombus. In contrast, 3.2 mg/mL aspirin, 40 IU/mL UFH or 4 mg/mL hirudin had no effect on a pre-formed thrombus. Altogether, this model constitutes a valuable platform to assess therapeutic strategies aimed at stabilizing or dissolving a thrombus.
No takes yet. Share an insight, caveat, or question.
Fauth et al. (2026) studied Arterial thrombosis. Antithrombotic agents (Cangrelor, GR 144053 trihydrochloride) vs. Saline was evaluated on Thrombus area (Area Under the Curve) (p=0.002). In a novel murine stable thrombosis model, administration of cangrelor or GR 144053 trihydrochloride 15 minutes after injury induced complete thrombus disaggregation and vessel recanalization.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: